User profiles for R. Costa

Rui M. Costa

- Verified email at columbia.edu - Cited by 17025

Rubén D. Costa

- Verified email at tum.de - Cited by 8485

Roberto Costa

- Verified email at incor.usp.br - Cited by 6709

Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases

…, C Altunbulakli, K Azkur, RA Costa, R Crameri… - Journal of Allergy and …, 2016 - Elsevier
There have been extensive developments on cellular and molecular mechanisms of
immune regulation in allergy, asthma, autoimmune diseases, tumor development, organ …

Luminescent ionic transition‐metal complexes for light‐emitting electrochemical cells

RD Costa, E Ortí, HJ Bolink, F Monti… - Angewandte Chemie …, 2012 - Wiley Online Library
Higher efficiency in the end‐use of energy requires substantial progress in lighting concepts.
All the technologies under development are based on solid‐state electroluminescent …

A deep learning framework for neuroscience

…, R Bogacz, A Christensen, C Clopath, RP Costa… - Nature …, 2019 - nature.com
Abstract Systems neuroscience seeks explanations for how the brain implements a wide
variety of perceptual, cognitive and motor tasks. Conversely, artificial intelligence attempts to …

[HTML][HTML] Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study

…, FJ Bruinsma, J Coresh, R Costa… - The Lancet Public …, 2020 - thelancet.com
Background Data for front-line health-care workers and risk of COVID-19 are limited. We
sought to assess risk of COVID-19 among front-line health-care workers compared with the …

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo …

LL Villa, RLR Costa, CA Petta, RP Andrade… - The lancet …, 2005 - thelancet.com
Background A randomised double-blind placebo-controlled phase II study was done to
assess the efficacy of a prophylactic quadrivalent vaccine targeting the human papillomavirus (…

[HTML][HTML] Warfarin prevents venous obstruction after cardiac devices implantation in high-risk patients: partial analysis

KR Silva, R Costa, RA Rached… - Brazilian Journal of …, 2008 - SciELO Brasil
Introduction: The incidence of venous thrombosis after cardiac devices implantation is high.
Ventricular dysfunction and previous transvenous temporary leads ipsilaterally to the …

Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

…, AM Cole, MR Fernandes, S Prescott, RGF Costa… - Science, 2021 - science.org
Anti–programmed cell death protein 1 (PD-1) therapy provides long-term clinical benefits to
patients with advanced melanoma. The composition of the gut microbiota correlates with anti…

Concurrent activation of striatal direct and indirect pathways during action initiation

…, X Jin, MD Pham, SS Vogel, DM Lovinger, RM Costa - Nature, 2013 - nature.com
Costa and colleagues have developed a new in vivo technique for monitoring the activity of
specific cell types deep in the brain via fibre optics, and use it to monitor activity in these two …

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial

…, D Salvadori, M Gusmão, R Staico, JR Costa… - Jama, 2013 - jamanetwork.com
Importance The current recommendation is for at least 12 months of dual antiplatelet therapy
after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet …

[HTML][HTML] High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

LL Villa, RLR Costa, CA Petta, RP Andrade… - British Journal of …, 2006 - nature.com
Human papillomavirus (HPV) causes cervical, vulvar, and vaginal cancers, precancerous
dysplasia, and genital warts. We report data for the longest efficacy evaluation to date of a …